Patel et al. [201] described the GRP78-targeting siRNAs self-assembled into nanostructures which exerted the GRP78 knockdown-associated cytotoxic effects on triple negative breast cancer-derived MDA-MB-231 cells in vitro. The gene discussed is HSPA5; the disease is triple-negative breast carcinoma.